Artiva Biotherapeutics vs Cervomed
Artiva Biotherapeutics and Cervomed are similar in size: $0 and $4.0m of revenue in their latest fiscal years. Cervomed grew faster (-58.9% against -100.0%). Artiva Biotherapeutics carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Artiva BiotherapeuticsARTV, 2025 | CervomedCRVO, 2025 |
|---|---|---|
| Revenue | $0 | $4.0m |
| Revenue growth | -100.0% | -58.9% |
| Net income | −$83.9m | −$27.0m |
| Operating margin | — | -706.2% |
| Net margin | — | -673.1% |
| Return on equity | -56.5% | -93.9% |
| Free cash flow | −$79.3m | −$23.4m |
| Cash | $26.7m | $8.2m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 104 | 15 |
| Market value | $165m | $21.0m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 19 buys, 0 sales |